Table 1. Characteristics of participants according to primary infection strain of SARS-CoV-2 (n=368).
Characteristic | Wild type infection | Alpha/Delta infection | Omicron infection | Total | |||||||
n | % | n | % | n | % | n | % | ||||
Abbreviation: SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. * Only 325 respondents had access to detailed vaccination information. | |||||||||||
Gender | |||||||||||
Male | 36 | 52.9 | 45 | 51.1 | 102 | 48.1 | 183 | 49.7 | |||
Female | 32 | 47.1 | 43 | 48.9 | 110 | 51.9 | 185 | 50.3 | |||
Age, years | |||||||||||
0–17 | 7 | 10.3 | 14 | 15.9 | 18 | 8.5 | 39 | 10.6 | |||
18–59 | 49 | 72.1 | 51 | 58.0 | 183 | 86.3 | 283 | 76.9 | |||
≥60 | 12 | 17.6 | 23 | 26.1 | 11 | 5.2 | 46 | 12.5 | |||
Occupation | |||||||||||
Medical worker | 4 | 5.9 | 3 | 3.4 | 20 | 9.4 | 27 | 7.3 | |||
Other | 64 | 94.1 | 85 | 96.6 | 192 | 90.6 | 341 | 92.7 | |||
Clinical manifestation of primary infection | |||||||||||
Asymptomatic | 13 | 19.1 | 14 | 15.9 | 47 | 22.2 | 74 | 20.1 | |||
Symptomatic | 55 | 80.9 | 74 | 84.1 | 165 | 77.8 | 294 | 79.9 | |||
SARS-CoV-2 vaccination status | |||||||||||
Unvaccinated | 0 | 0 | 4 | 4.5 | 4 | 1.9 | 8 | 2.2 | |||
Incomplete | 7 | 10.3 | 9 | 10.2 | 9 | 4.2 | 25 | 6.8 | |||
Complete | 12 | 17.6 | 39 | 44.3 | 52 | 24.5 | 103 | 28.0 | |||
Booster | 34 | 50.0 | 34 | 38.6 | 121 | 57.1 | 189 | 51.4 | |||
No detail | 15 | 22.1 | 2 | 2.3 | 26 | 12.3 | 43 | 11.7 | |||
Interval since last vaccination* | |||||||||||
Unvaccinated | 0 | 0.0 | 4 | 4.7 | 4 | 2.2 | 8 | 2.5 | |||
<12 months | 26 | 49.1 | 74 | 86.0 | 50 | 26.9 | 150 | 46.2 | |||
≥12 months | 27 | 50.9 | 8 | 9.3 | 132 | 71.0 | 167 | 51.4 | |||
Reinfection status | |||||||||||
Non-reinfection | 34 | 50.0 | 57 | 64.8 | 173 | 81.6 | 264 | 71.7 | |||
Reinfection | 34 | 50.0 | 31 | 35.2 | 39 | 18.4 | 104 | 28.3 | |||
Probable case | 7 | 10.3 | 6 | 6.8 | 21 | 9.9 | 34 | 9.2 | |||
Confirmed case | 27 | 39.7 | 25 | 28.4 | 18 | 8.5 | 70 | 19.0 |